Kelgtermans; Hans

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kelgtermans; Hans.The latest application filed is for "heteroaryl substituted pyridines and methods of use".

Company Profile

3.9.9

Kelgtermans; Hans - Mechelen BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Heteroaryl substituted pyridines and methods of use Grant 10,604,515 - Altenbach , et al.	2020-03-31
Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis Grant 10,568,867 - Van der Plas , et al. Feb	2020-02-25
Heteroaryl Substituted Pyridines and Methods of Use App 20190055229 - Altenbach; Robert J. ; et al.	2019-02-21
Heteroaryl substituted pyridines and methods of use Grant 10,138,227 - Altenbach , et al. Nov	2018-11-27
Substituted pyridines and method of use Grant 10,047,051 - Altenbach , et al. August 14, 2	2018-08-14
Novel Compounds And Pharmaceutical Compositions Thereof For The Treatment Of Cystic Fibrosis App 20180221334 - VAN DER PLAS; Steven Emiel ; et al.	2018-08-09
Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis Grant 9,895,347 - Van Der Plas , et al. February 20, 2	2018-02-20
Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis Grant 9,867,806 - De Blieck , et al. January 16, 2	2018-01-16
Heteroaryl Substituted Pyridines And Methods Of Use App 20170349576 - Altenbach; Robert J. ; et al.	2017-12-07
Substituted Pyridines And Method Of Use App 20160355480 - Altenbach; Robert J. ; et al.	2016-12-08
Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Cystic Fibrosis App 20160317493 - VAN DER PLAS; Steven Emiel ; et al.	2016-11-03
Novel Compounds And Pharmaceutical Compositions Thereof For The Treatment Of Cystic Fibrosis App 20160263084 - De Blieck; Ann ; et al.	2016-09-15
Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis Grant 9,382,254 - De Blieck , et al. July 5, 2	2016-07-05
Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis Grant 9,351,955 - Van Der Plas , et al. May 31, 2	2016-05-31
Novel Compounds And Pharmaceutical Compositions Thereof For The Treatment Of Cystic Fibrosis App 20160022633 - VAN DER PLAS; Steven Emiel ; et al.	2016-01-28
Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis Grant 9,133,210 - Van Der Plas , et al. September 15, 2	2015-09-15
Novel Compounds And Pharmaceutical Compositions Thereof For The Treatment Of Cystic Fibrosis App 20150045327 - VAN DER PLAS; Steven Emiel ; et al.	2015-02-12
Novel Compounds And Pharmaceutical Compositions Thereof For The Treatment Of Cystic Fibrosis. App 20150005275 - Plas; Steven Emiel Van der ; et al.	2015-01-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.